Areas of focus

The MORE® research group conducts research in the following areas:

  • health economics
  • pharmacoeconomics
  • health outcomes and technology assessment

This research is relevant to the following groups:

  • academia
  • formulary bodies
  • decision makers
  • the pharmaceutical industry
  • third-party payers

Our therapeutic foci are CNS and cardiovascular medications, and relevant outcomes. In particular, we have extensive experience in designing and conducting prospective studies. We also have expertise in meta-analyses, resource utilization, quality of life assessment, modelling and costing.